SCHEMBL6958533

SCHEMBL6958533

COc1cccc(CSc2c(O)cc(-c3ccccc3)oc2=O)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAO P14920 1/20 0.47
PIK3CG P48736 1/20 0.46
CYP1A2 P05177 1/20 0.45
TSHR P16473 3/20 0.45
NPC1 O15118 1/20 0.45
ABCB1 P08183 1/20 0.45
CYP3A4 P08684 1/20 0.45
MAPT P10636 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
ABCG2 Q9UNQ0 1/20 0.45
CYP19A1 P11511 2/20 0.44
PIK3CB P42338 1/20 0.44
TNKS O95271 1/20 0.44
CTSB P07858 1/20 0.44
NTRK1 P04629 1/20 0.44
NTRK2 Q16620 1/20 0.44
ABL1 P00519 1/20 0.43
VKORC1 Q9BQB6 1/20 0.43
TDP1 Q9NUW8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6965060 0.93 CYP3A4 (0.46) DAOPIK3CGCYP1A2TSHRNPC1
SCHEMBL6957750 0.90 ABCB1 (0.44) DAOTSHRNPC1ABCB1CYP3A4
SCHEMBL6960312 0.90 SMN1; SMN2 (0.41) CYP1A2NPC1ABCB1CYP3A4MAPT
SCHEMBL6958649 0.89 NTRK1 (0.51) DAOPIK3CGCYP1A2TSHRNPC1
SCHEMBL6956208 0.89 NTRK1 (0.48) DAOTSHRNPC1ABCB1CYP3A4
SCHEMBL6965173 0.88 ABCB1 (0.52) NPC1ABCB1MAPTCYP19A1KMT2A
SCHEMBL6966105 0.86 SLC16A3 (0.43) ABCB1MAPTABL1KMT2AL3MBTL1
SCHEMBL6954786 0.86 SMN1; SMN2 (0.50) DAOCYP1A2ABCB1CYP3A4MAPT
SCHEMBL6964536 0.85 DAO (0.46) DAOCYP1A2NPC1CYP3A4MAPT
SCHEMBL6963884 0.84 GSK3B (0.48) TSHRNPC1TNKSPTGDR2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP claimed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO claimed
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed